NCT06776094

Brief Summary

The study investigates the role of one single bout of exercise in mediating enhancement of muscle insulin sensitivity following a single bout of exercise. Furthermore, the study is aiming to elucidate the temporal development in insulin signaling, at the early timepoints of insulin stimulation that may be responsible for the enhanced muscle insulin sensitivity. This will be investigated in young healthy males subjected to a one-legged knee-extensor exercise followed by a hyperinsulinemic-euglycemic clamp, a setup known to enhance muscle insulin sensitivity.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started May 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
May 2025Jan 2027

First Submitted

Initial submission to the registry

January 9, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 15, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

May 5, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 26, 2025

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Expected
Last Updated

December 2, 2025

Status Verified

December 1, 2025

Enrollment Period

4 months

First QC Date

January 9, 2025

Last Update Submit

December 1, 2025

Conditions

Keywords

ExerciseMuscle insulin sensitivityMuscle glucose uptakeGLUT4Phosphoproteomics

Outcome Measures

Primary Outcomes (1)

  • Insulin stimulated muscle glucose uptake

    Muscle glucose uptake during insulin stimulation in recovery from exercise (insulin sensitivity) will be determined based on Fick's principle. Thus, femoral arterio-venous difference (av difference) in blood glucose concentration will be multiplied by femoral arterial leg blood flow.

    Through study completion, approx. 1 year.

Secondary Outcomes (1)

  • Posttranslational modification of proteins in muscle biopsies

    3 years

Other Outcomes (2)

  • Imaging of transport protein

    1 year

  • Maximum oxygen uptake

    Through study completion, approx. 1 year.

Study Arms (1)

Post-exercise insulin sensitivity

EXPERIMENTAL

Young healthy males will perform a single bout of knee-extensor exercise and insulin action is investigated 4 hours after cessation of exercise. Insulin action towards muscle glucose uptake will be investigated during a 120 min euglycemic hyperinsulinemic clamp.

Other: One-legged-knee extensor exerciseProcedure: Insulin infusionProcedure: Muscle Biopsy Medication: LidocaineOther: Exercise

Interventions

1 hour of one-legged-knee-extensor exercise followed by 4 hours of rest

Post-exercise insulin sensitivity

The hyperinsulinemic-euglycemic clamp is a well-established and recognized method for determining glucose uptake at a specific insulin infusion rate. It is a technique with which we have 25 years of uncomplicated experience. During the clamp, insulin (human recombinant insulin) is infused (1.42 mU/kg/min) into an arm vein (antecubital vein), while glucose (20% solution) is administered in an amount adjusted to maintain blood glucose (plasma glucose concentration) at basal levels. The amount of insulin administered raises the participant's plasma insulin concentration (blood concentration) to approximately 100 μU/mL, which is considered within the physiological range. Blood samples are collected and analyzed continuously for glucose content, allowing for the determination of glucose uptake at the whole-body level and across the legs. Later, these blood samples will also be analyzed for relevant metabolites and proteins, including insulin, to assess the metabolism of these substances.

Post-exercise insulin sensitivity

During supine rest, the skin on the outer thigh, approximately 15 cm above the knee, is disinfected with chlorhexidine alcohol. Subsequently, 3-4 mL of local anesthetic (lidocaine 20 mg/mL) is administered into the skin, subcutaneous tissue, and the upper portion of the muscle using a very thin needle. A pinprick test is performed after a few minutes to ensure the anesthetic is effective. A small incision is then made in the skin and subcutaneous tissue to allow the biopsy needle to pass through to the muscle. Using the biopsy needle, a small sample of muscle tissue (approximately 150 mg) is collected. This may cause some discomfort but is very brief (\~1-2 seconds). The needle is removed, a sterile dressing is applied, and the participant can leave the facility after completing the study. The biopsy may result in mild muscle soreness for 2-3 days, similar to a minor muscle bruise. Regular physical activities can be resumed after the biopsy. However, it is advised to avoid swimming.

Post-exercise insulin sensitivity

The participants' maximal oxygen uptake is determined through a test on a cycle ergometer before the start of the experiment. The test begins with a 20-minute warm-up at two different low workloads, after which the workload is gradually increased until the predetermined cadence can no longer be maintained, or the participant indicates exhaustion. During the test, the participant's exhaled air is collected. After completing the warm-up, it typically takes between 4 and 7 minutes to complete the test.

Post-exercise insulin sensitivity

Eligibility Criteria

Age22 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy individuals (no known diseases)
  • No use of medication
  • Non-smokers
  • Male
  • Aged 22-35 years
  • Fitness level (VO2max, i.e., maximal oxygen uptake) between 30-50 mL O2/min/kg
  • BMI between 28 and 35

You may not qualify if:

  • Women
  • Physical activity level (e.g., running, cycling, fitness, etc.) exceeding 6 hours per week
  • Acute illness within 2 weeks prior to the study days
  • Use of recreational drugs within 2 weeks prior to the study days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Copenhagen, August Krogh Section for Human and Molecular Physiology

Copenhagen, 2100, Denmark

RECRUITING

MeSH Terms

Conditions

Insulin ResistanceMotor Activity

Interventions

Insulin Infusion SystemsExercise

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesBehavior

Intervention Hierarchy (Ancestors)

Drug Delivery SystemsDrug TherapyTherapeuticsInfusion PumpsEquipment and SuppliesArtificial OrgansSurgical EquipmentMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Jørgen FP Wojtaszewski, Prodessor

    Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Denmark

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jørgen FP Wojtaszewski, Professor

CONTACT

Nicolai S Henriksen, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 9, 2025

First Posted

January 15, 2025

Study Start

May 5, 2025

Primary Completion

August 26, 2025

Study Completion (Estimated)

January 1, 2027

Last Updated

December 2, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations